Pancreatic Cancer Research

ResearcherIRCCS Ospedale San RaffaeleActive in the last 2 years

Claudio Fiorino

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0013-8494; OpenAlex author ID A5033023713, A5082791089. Sources: OpenAlex.

Their work

Papers
10 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
33
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 10

  1. Pancreatic adenocarcinoma nutritional-clinical index (PANCIN): A novel prognostic tool in advanced pancreatic cancer. Co-author DOI 10.1016/j.dld.2026.02.015↗
  2. A robust biomarker combining radiomic and CA19.9 information to predict distant relapse-free survival after radiochemotherapy in pancreatic cancer. Co-author DOI 10.1016/j.dld.2026.09.026↗
  3. Temporal Validation of an FDG-PET-Radiomic Model for Distant-Relapse-Free-Survival After Radio-Chemotherapy for Pancreatic Adenocarcinoma. Co-author DOI 10.3390/cancers17061036↗
  4. Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ctro.2024.100778↗
  5. Limited impact of discretization/interpolation parameters on the predictive power of CT radiomic features in a surgical cohort of pancreatic cancer patients. Last author DOI 10.1007/s11547-023-01649-y↗
  6. Proposal for a New Pathologic Prognostic Index After Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma (PINC). Co-author DOI 10.1245/s10434-022-11413-7↗
  7. Stomach and duodenum dose-volume constraints for locally advanced pancreatic cancer patients treated in 15 fractions in combination with chemotherapy. Last author DOI 10.3389/fonc.2022.983984↗
  8. Prediction of Early Distant Recurrence in Upfront Resectable Pancreatic Adenocarcinoma: A Multidisciplinary, Machine Learning-Based Approach. Co-author DOI 10.3390/cancers13194938↗
  9. Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemotherapy for locally advanced pancreatic … Last author DOI 10.1016/j.radonc.2020.07.003↗
  10. Quantifying the robustness of [18F]FDG-PET/CT radiomic features with respect to tumor delineation in head and neck and pancreatic cancer patients. Last author DOI 10.1016/j.ejmp.2018.05.013↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michele Reni · 8 shared papers, 2020–2026 · strength 1.34
  2. Martina Mori · 7 shared papers, 2018–2025 · strength 0.95
  3. Nadia Gisella Di Muzio · 6 shared papers, 2018–2026 · strength 0.93
  4. Paolo Passoni · 6 shared papers, 2018–2026 · strength 0.93
  5. Massimo Falconi · 5 shared papers, 2021–2026 · strength 0.84
  6. M. De Vincenzi · 3 shared papers, 2025–2026 · strength 0.66
  7. Marina Macchini · 3 shared papers, 2024–2026 · strength 0.63
  8. Giulia Orsi · 3 shared papers, 2024–2026 · strength 0.63
  9. Maria Picchio · 4 shared papers, 2018–2026 · strength 0.60
  10. Diego Palumbo · 3 shared papers, 2021–2026 · strength 0.51
  11. Sara Broggi · 4 shared papers, 2018–2024 · strength 0.49
  12. Catia Carconi · 2 shared papers, 2026 · strength 0.45
  13. Gianpaolo Balzano · 2 shared papers, 2022–2024 · strength 0.33
  14. Giulio Belfiori · 2 shared papers, 2021–2024 · strength 0.29
  15. Domenico Tamburrino · 2 shared papers, 2021–2024 · strength 0.29
  16. Stefano Cascinu · 2 shared papers, 2021–2024 · strength 0.29
  17. Francesco DE COBELLI · 2 shared papers, 2021–2023 · strength 0.28
  18. Stefano Crippa · 2 shared papers, 2021–2023 · strength 0.28
  19. Giovanni Guarneri · 1 shared paper, 2026 · strength 0.23
  20. Nicolò Pecorelli · 1 shared paper, 2026 · strength 0.23
  21. Gabriele Capurso · 1 shared paper, 2026 · strength 0.23
  22. Giuseppe Vanella · 1 shared paper, 2026 · strength 0.23
  23. Martina Mori · 1 shared paper, 2026 · strength 0.22
  24. Giovanni Mauro Cattaneo · 2 shared papers, 2018–2022 · strength 0.21
  25. Umberto Peretti · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.